Vitamins & Minerals

Michael J. Gonzalez

Michael J. Gonzalez
Professor
University of Puerto Rico, School of Public Health, USA

Biography

Dr. Michael J. Gonzalez is a professor at the nutrition program at the Graduate School of Public Health at the Medical Sciences Campus of the University of Puerto Rico. It is also functional program faculty Medicine University of Western States in Portland, Oregon and program faculty Naturopathic Medicine EDP University in San Juan, Puerto Rico Dr. Gonzalez is a Fellow of the American College of Nutrition and author of more than 150 scientific publications. Serves as a member of several editorial boards of scientific journals and serves as a scientific consultant for various companies. He has been responsible for designing formulations of nutritional supplements and pharmaceuticals. He has won several research awards for his work on nutrition and cancer. He is currently Co - RECNAC II project director and director of research InBioMed initiative. Dr. Gonzalez also serves as a nutrition consultant for the national basketball team of Puerto Rico.
Dr. Gonzalez is a leader in the development of non-toxic cancer treatments. His group published the first-stage clinical study using intravenous vitamin C for the treatment of patients with terminal cancer in 2005 and in 2005 published the most comprehensive review on vitamin C and cancer, as a follow up of the work of two time winner of the Nobel, Dr. Linus Pauling Award. He has developed many new concepts such as bioenergetics theory of carcinogenesis, the phenomenon of systemic intravenous vitamin C saturation, the concept of metabolic correction for prevention and treatment of disease. His book (with Drs. -Massari And Saul Miranda) "I have cancer do I do?" It has received excellent reviews. Dr. Gonzalez has a clinical practice in nutritional medicine with Dr. Miguel J. Berdiel in Ponce, Puerto Rico.
 

Research Interest

Main Research Interest is the development of effective, non-toxic treatments for chronic diseases, especially cancer. Changing the biochemical conditions that promote, develop and sustain the malignant state can produce inhibition of malignant cell proliferation, increase aerobic metabolism and achieve re-differentiation. We are also interested in the development of non-toxic therapeutic strategies that enhance the effectiveness of other treatments or that reduce their toxicity. Ascorbic acid, lipoic acid, acetyl L-Carnitine, Coenzyme Q10, magnesium and phospholipids to achieve Mitochondrial correction.